Personensuche
Personensuche
Es wurde 1 Person gefunden.
Klinik für Frauenheilkunde und Geburtshilfe am Universitätsklinikum Essen
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
E-Mail
Funktionen
-
Mitglied/er, Klinik für Frauenheilkunde und Geburtshilfe
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
2017 SS
- Wahlfach: Praxis der gynäkologischen und geburtshilflichen Diagnostik (*)
- Vorlesung Frauenheilkunde und Geburtshilfe (7. FS WA) (3. Semester des zweiten Studienabschnittes)
- Blockpraktikum Frauenheilkunde und Geburtshilfe (8. FS PV) (4. Semester des zweiten Studienabschnittes)
- Gynäkologisches Seminar für Blockpraktikanten (PV)
- Seminar Geburtshilfe für Blockpraktikanten (8. FS PV)
- Anamnese Seminar für Blockpraktikanten (8. FS PV)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialIn: Clinical Chemistry Jg. 70 (2024) Nr. 1, S. 307 - 318Online Volltext: dx.doi.org/
-
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancerIn: Archives of Gynecology and Obstetrics Jg. 309 (2024) Nr. 6, S. 2789 - 2798Online Volltext: dx.doi.org/ (Open Access)
-
Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrenceIn: Anticancer Research Jg. 43 (2023) Nr. 2, S. 733 - 739Online Volltext: dx.doi.org/
-
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on ¹⁸F-FDG PET/MRI and Machine LearningIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 304 - 311Online Volltext: dx.doi.org/ (Open Access)
-
Conventional Imaging, MRI and ¹⁸F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast CancerIn: Cancers Jg. 15 (2023) Nr. 14, 3646Online Volltext: dx.doi.org/ (Open Access)
-
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerIn: Cancers Jg. 15 (2023) Nr. 6, 1651Online Volltext: dx.doi.org/ (Open Access)
-
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patientsIn: Frontiers in Immunology Jg. 14 (2023) 1188030Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapyIn: Cancer Treatment Reviews Jg. 121 (2023) 102631Online Volltext: dx.doi.org/
-
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer : Prospective Cohort StudyIn: The Oncologist Jg. 28 (2023) Nr. 12, S. e1152 - e1159Online Volltext: dx.doi.org/ (Open Access)
-
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrantIn: Trials Jg. 24 (2023) Nr. 1, 338Online Volltext: dx.doi.org/ (Open Access)
-
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapseIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 3, S. 1159 - 1174Online Volltext: dx.doi.org/ (Open Access)
-
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancerIn: Scientific Reports Jg. 13 (2023) Nr. 1, 21262Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy : Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trialIn: Annals of Oncology Jg. 34 (2023) Nr. 8, S. 660 - 669Online Volltext: dx.doi.org/ (Open Access)
-
Towards a fast PET/MRI protocol for breast cancer imaging : maintaining diagnostic confidence while reducing PET and MRI acquisition timesIn: European Radiology Jg. 33 (2023) Nr. 9, S. 6179 - 6188Online Volltext: dx.doi.org/ (Open Access)
-
Von der Mastitis zum Multiorganversagen : Ein seltenes, potenziell tödliches ProblemIn: Die Gynäkologie Jg. 56 (2023) Nr. 1, S. 58 - 61Online Volltext: dx.doi.org/ (Open Access)
-
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)In: ESMO Open Jg. 7 (2022) Nr. 6, 100601Online Volltext: dx.doi.org/ (Open Access)
-
Breast Radiation Exposure of 3D Digital Breast Tomosynthesis Compared to Full-Field Digital Mammography in a Clinical Follow-Up SettingIn: Diagnostics Jg. 12 (2022) Nr. 2, 456Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Comparison of nodal staging between CT, MRI, and [¹⁸F]-FDG PET/MRI in patients with newly diagnosed breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 992 - 1001Online Volltext: dx.doi.org/ (Open Access)
-
Complications and satisfaction in transwomen receiving breast augmentation : short- and long-term outcomesIn: Archives of Gynecology and Obstetrics Jg. 305 (2022) Nr. 6, S. 1517 - 1524Online Volltext: dx.doi.org/ (Open Access)
-
Die Mammareduktionsplastik – doch mehr als eine rein plastische Operation? : Ergebnisse einer Studie an der Frauenklinik des Universitätsklinikums EssenIn: Die Gynäkologie Jg. 55 (2022) Nr. 9, S. 690 - 701Online Volltext: dx.doi.org/ (Open Access)
-
Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRIIn: EJNMMI Physics Jg. 9 (2022) Nr. 1, 11Online Volltext: dx.doi.org/ (Open Access)
-
In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor CellsIn: Cancers Jg. 14 (2022) Nr. 14, 3299Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI : Clinically Relevant?In: Cancers Jg. 14 (2022) Nr. 14, 3454Online Volltext: dx.doi.org/ (Open Access)
-
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 15, 8716Online Volltext: dx.doi.org/ (Open Access)
-
Multiparametric¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerIn: Cancers Jg. 14 (2022) Nr. 7, 1727Online Volltext: dx.doi.org/ (Open Access)
-
Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial : Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trialIn: Frontiers in Medicine Jg. 9 (2022) 967964Online Volltext: dx.doi.org/ (Open Access)
-
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflowIn: Breast Cancer: The Journal of the Japanese Breast Cancer Society Jg. 29 (2022) Nr. 3, S. 487 - 497Online Volltext: dx.doi.org/ (Open Access)
-
Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients : UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease OutcomeIn: Frontiers in Immunology Jg. 12 (2022) 817132Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant ChemotherapyIn: Breast Care Jg. 17 (2022) Nr. 4, S. 371 - 376Online Volltext: dx.doi.org/ (Open Access)
-
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer : A Comparative Study Using Histopathology as the Reference StandardIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1677 - 1683Online Volltext: dx.doi.org/ (Open Access)
-
Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysisIn: European Journal of Cancer (EJC) Jg. 154 (2021) S. 128 - 137Online Volltext: dx.doi.org/
-
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer : Real-world experience from >2000 patients treated in the multicentre AVANTI studyIn: The Breast Jg. 60 (2021) S. 70 - 77Online Volltext: dx.doi.org/ (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine Jg. 13 (2021) Nr. 1, 85Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer PatientsIn: Cells Jg. 10 (2021) Nr. 2, S. 212Online Volltext: dx.doi.org/ (Open Access)
-
Multiparametric integrated¹⁸f-fdg pet/mri-based radiomics for breast cancer phenotyping and tumor decodingIn: Cancers Jg. 13 (2021) Nr. 12, 2928Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programIn: ESMO Open Jg. 6 (2021) Nr. 6, 100299Online Volltext: dx.doi.org/ (Open Access)
-
Prospective comparison of CT and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients : Initial resultsIn: PLoS ONE Jg. 16 (2021) e0260804Online Volltext: dx.doi.org/ (Open Access)
-
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsIn: European Radiology Jg. 31 (2021) Nr. 11, S. 8714 - 8724Online Volltext: dx.doi.org/ (Open Access)
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 8, S. 2233 - 2238Online Volltext: dx.doi.org/ (Open Access)
-
Zinc distribution within breast cancer tissue of different intrinsic subtypesIn: Archives of Gynecology and Obstetrics Jg. 303 (2021) S. 195 - 205Online Volltext: dx.doi.org/ (Open Access)
-
A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancerIn: PLoS ONE Jg. 15 (2020) S. e0234871Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisIn: Therapeutic Advances in Medical Oncology Jg. 12 (2020)Online Volltext: dx.doi.org/ (Open Access)
-
Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast CancerIn: Frontiers in Oncology Jg. 10 (2020) S. 1658Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Circulating tumor cells expressing the prostate specific membrane antigen PSMA indicate worse outcome in triple-negative breast cancer patients at primary diagnosisIn: Cancer Research Jg. 80 (2020) Nr. 4,Online Volltext: dx.doi.org/
-
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsIn: The Breast Jg. 50 (2020) S. 11 - 18Online Volltext: dx.doi.org/ (Open Access)
-
High serum levels of periostin are associated with a poor survival in breast cancerIn: Breast Cancer Research and Treatment Jg. 180 (2020) Nr. 2, S. 515 - 524Online Volltext: dx.doi.org/
-
Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithmsIn: European Journal of Radiology Jg. 128 (2020) S. 108975Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ki67 as a predictive biomarker for pathologic complete remission in patients with eraly triple negative breast cancer (TNBC) receiving carboplatin-containing neoadjuvant chemotherapy (NACT)In: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 6, S. e20Online Volltext: dx.doi.org/
-
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patientsIn: Journal of Cellular and Molecular Medicine Jg. 24 (2020) Nr. 15, S. 8405 - 8416Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patientsIn: Cancers Jg. 12 (2020) Nr. 5,Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prospective evaluation of whole-body MRI and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 12, S. 2816 - 2825Online Volltext: dx.doi.org/ (Open Access)
-
Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth systemIn: European Journal of Cancer (EJC) Jg. 138 (2020) S. S68Online Volltext: dx.doi.org/
-
The Abscopal Effect : Could a Phenomenon Described Decades Ago Become Key to Enhancing the Response to Immune Therapies in Breast Cancer?In: Breast Care Jg. 15 (2020) Nr. 5, S. 443 - 449Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research Jg. 80 (2020) Nr. 4,Online Volltext: dx.doi.org/
-
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerIn: Breast Cancer Research and Treatment Jg. 174 (2019) Nr. 2, S. 453 - 461Online Volltext: dx.doi.org/
-
Can a brief psychological expectancy intervention improve postoperative pain? : A randomized, controlled trial in patients with breast cancerIn: Pain Jg. 160 (2019) Nr. 7, S. 1562 - 1571Online Volltext: dx.doi.org/
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers Jg. 11 (2019) Nr. 2, S. 238Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerIn: BMC Cancer Jg. 19 (2019) Nr. 1, S. 120Online Volltext: dx.doi.org/ (Open Access)
-
High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,Online Volltext: dx.doi.org/
-
In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survivalIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,Online Volltext: dx.doi.org/
-
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsIn: International Journal of Cancer Jg. 145 (2019) Nr. 8, S. 2114 - 2121Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic value of RANKL/OPG serum levels and disseminated tumor cells in nonmetastatic breast cancerIn: Clinical Cancer Research Jg. 25 (2019) Nr. 4, S. 1369 - 1378Online Volltext: dx.doi.org/ (Open Access)
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,Online Volltext: dx.doi.org/
-
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapyIn: OncoImmunology Jg. 7 (2018) Nr. 1, e1376153Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Local and whole-body staging in patients with primary breast cancer : a comparison of one-step to two-step staging utilizing ¹⁸F-FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 13, S. 2328 - 2337Online Volltext: dx.doi.org/
-
An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 CasesIn: Technology in Cancer Research & Treatment (TCRT) Jg. 16 (2017) Nr. 6, S. 1079 - 1082Online Volltext: dx.doi.org/ (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrowIn: Cancer Research Jg. 77 (2017) Nr. 4,Online Volltext: dx.doi.org/
-
Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast CancerIn: Breast Care Jg. 12 (2017) Nr. 5, S. 318 - 323Online Volltext: dx.doi.org/ (Open Access)
-
B3-lesions of the breast and cancer risk - an analysis of mammography screening patientsIn: Molecular and Clinical Oncology Jg. 4 (2016) Nr. 5, S. 705 - 708Online Volltext: dx.doi.org/
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 3152Online Volltext: dx.doi.org/
-
Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profilesIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P2-02-05Online Volltext: dx.doi.org/
-
Cyclic volatile methylsiloxanes in human blood as markers for ruptured silicone gel-filled breast implantsIn: Analytical and Bioanalytical Chemistry Jg. 408 (2016) Nr. 12, S. 3309 - 3317Online Volltext: dx.doi.org/
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Scientific Reports Jg. 6 (2016) S. 26355Online Volltext: dx.doi.org/ (Open Access)
-
Distant metastasis detected by routine staging in breast cancer patients participating in the national German screening programme : consequences for clinical practiceIn: SpringerPlus Jg. 5 (2016) Nr. 1, S. 1010Online Volltext: dx.doi.org/ (Open Access)
-
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? : Analysis of disseminated and circulating tumor cells before and after therapyIn: Breast Cancer Research Jg. 18 (2016) 20Online Volltext: dx.doi.org/ (Open Access)
-
In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcomeIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P2-02-01Online Volltext: dx.doi.org/
-
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Human Immunology Jg. 77 (2016) Nr. 9, S. 791 - 799Online Volltext: dx.doi.org/
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Cancer Research Jg. 75 (2015) Nr. 9 Suppl.,Online Volltext: dx.doi.org/
-
Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-upIn: Archives of Gynecology and Obstetrics Jg. 292 (2015) Nr. 5, S. 1117 - 1125Online Volltext: dx.doi.org/
-
Molecular characterization of circulating tumor cells allows stratifying for prognosis in breast cancer patients undergoing neoadjuvant therapyIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,Online Volltext: dx.doi.org/
-
Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer : A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance ImagingIn: Investigative Radiology Jg. 50 (2015) Nr. 8, S. 505 - 513Online Volltext: dx.doi.org/
-
The prognostic impact of soluble HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Tissue Antigens Jg. 86 (2015) Nr. 2, S. 81Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88Online Volltext: dx.doi.org/
-
Wie sicher sind Silikonimplantate wirklich? : BrustprothesenIn: MMW - Fortschritte der Medizin Jg. 155 (2013) Nr. 2, S. 50 - 52Online Volltext: dx.doi.org/
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsIn: Breast Cancer Research Jg. 14 (2012) Nr. 1, R15Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients : Initial resultsIn: Acta Radiologica Jg. 53 (2012) Nr. 6, S. 628 - 636Online Volltext: dx.doi.org/
-
Circulating 20S proteasome in patients with non-metastasized breast cancerIn: Anticancer Research Jg. 31 (2011) Nr. 6, S. 2197 - 2201(Open Access)
-
Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer : A pilot studyIn: Anticancer Research Jg. 31 (2011) Nr. 10, S. 3623 - 3628
-
Intraoperative Irradiation of the Tumor bed as a Boost in the Burst-sustaining Primary treatment of Breast cancer - Initial results and issues that arisesIn: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 99 - 100
-
Prädiktoren psychischer Belastungen bei Brustkrebspatientinnen : Worauf sollten Ärzte und Pflegekräfte in der onkologischen Praxis achten?In: Geburtshilfe und Frauenheilkunde Jg. 71 (2011) Nr. 4, S. 285 - 291Online Volltext: dx.doi.org/
-
Abstract P3-02-09: Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Primary Breast Cancer Patients with Circulating Tumor CellsIn: Cancer Research Jg. 70 (2010) Nr. 24, S. P3 - 02Online Volltext: dx.doi.org/
-
Effect of ibandronate on tumor cells in the bone marrow and in blood in patients with primary breast cancer : A pilot study
IBMS Davos Workshops: Bone Biology & Therapeutics; 14-19 March 2010; Davos, Switzerland,In: Bone: Official Journal of the International Bone and Mineral Society (IBMS) Jg. 46 (2010) Nr. Suppl. 1, S. S38Online Volltext: dx.doi.org/ -
Die Magnetresonanztomographie(MRT)-gesteuerte Mamma-Vakuumbiopsie mit dem Vacora®-System : Erste ErgebnisseMR-Guided Vacuum Assisted Breast BiopsyInitial ResultsIn: Zentralblatt für Gynäkologie Jg. 127 (2005) Nr. 6, S. 400 - 406Online Volltext: dx.doi.org/
-
Prognostic relevance of activated Akt kinase in node-negative breast cancer : A clinicopathological study of 99 casesIn: Modern Pathology Jg. 17 (2004) Nr. 1, S. 15 - 21Online Volltext: dx.doi.org/ (Open Access)
-
Neoadjuvant dynamic marker-adjusted personalized therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel + carboplatin + trastuzumab + pertuzumab in HER2+ early breast cancer : WSG-ADAPT-HER2-IVIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, TPS631Online Volltext: dx.doi.org/ (Open Access)
-
A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE)In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 1292 - S1293Online Volltext: dx.doi.org/ (Open Access)
-
Association between mammographic breast density and achievement of a pathologic complete remission (pCR) after neoadjuvant chemotherapy (NACT) for early breast cancer (EBC)In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl., S. e12611Online Volltext: dx.doi.org/
-
Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancerIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 496 - S497Online Volltext: dx.doi.org/ (Open Access)
-
Organ Stress with an optimized tangential IMRT-Technique in the Irradiation of the Breast/Thoracic Wall and the regional Lymphatic Drainage Pathways in Patients with locally advanced Breast CancerIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 137 - S138
-
Targeted breast surgery : Non-direct approach
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. Suppl. 15, e12602Online Volltext: dx.doi.org/ (Open Access) -
The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_suppl, S. e12553Online Volltext: dx.doi.org/ (Open Access) -
Incidence and Resolution of Eribulin-induced peripheral NEuropathy (IRENE)
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 165Online Volltext: dx.doi.org/ (Open Access) -
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research Jg. 80 (2020) Nr. Suppl. 16, S. 5366Online Volltext: dx.doi.org/ -
Real-world efficacy of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer : Second interim analysis from the RIBANNA study
San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas,In: Cancer Research Jg. 80 (2020) Nr. 4, Supplement, P1-19-33Online Volltext: dx.doi.org/ -
Sentinel lymphnode biopsy (SLNB) and targeted axillary surgery (TAS) by indocyaningreen (ICG) and a novel near-infrared color camera system : a prospectively randomised, multicenter study to avoid radioactivity in a time-/cost-saving procedure in primary breast cancer
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research Jg. 78 (2018) Nr. 4, Supplement, OT2-01-05Online Volltext: dx.doi.org/ -
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow
2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des congrès de Montréal in Montréal, Quebéc, Canada September 28 – October 1, 2018,In: Journal of Bone and Mineral Research (JBMR) Jg. 33 (2018) Nr. Suppl. 1, S. 72 - 73 -
Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes : Do we have therapeutic options?
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research Jg. 78 (2018) Nr. 4, Supplement, P2-01-06Online Volltext: dx.doi.org/ -
Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer : A ten year follow-upIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P4-04-07Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19Online Volltext: dx.doi.org/ (Open Access)
-
CK-19, MAGE-A3, HER-2 and TWIST-1 expression by RT-qPCR in CTCs of primary breast cancer patients after positive immune-magnetic selection using anti-EpCAM and anti-MUC1 magnetic beadsIn: Cancer Research Jg. 71 (2011) Nr. 8, Suppl., S. 4150Online Volltext: dx.doi.org/
-
Are bisphosphonate ibandronate influence disseminated tumor cells in the bone marrow and circulating blood tumor cells in patients with primary breast cancers? Presentation of a pilot studyIn: Onkologie Jg. 33 (2010) Nr. Suppl.2, S. 38 - 38
-
Von der B3 Läsion bis zum primären Mammakarzinom Die Problematik der minimalen Tumorresterkrankung und ihre therapeutische Herausforderung : die Problematik der minimalen Tumorresterkrankung und ihre therapeutische HerausforderungDuisburg ; Essen (2017) 1 CD-ROM
-
98P Final results from AVANTI, a multicentre German observational study of first-line bevacizumab (BEV) + chemotherapy (CT) in >2000 patients (pts) with advanced breast cancer (aBC)In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 2, S. S65Online Volltext: dx.doi.org/ (Open Access)
-
A clustering and mutual information based analysis of the ELIMA study results : The additive value of multi-parametric liquid biopsies, including CTCs, EVs and cfDNA, in metastatic breast cancer
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS6 - 60Online Volltext: dx.doi.org/ -
Dynamics of a multi-parametric liquid biopsy, including CTCs, EVs, and cfDNA, during therapy in metastatic breast cancer patients provide useful insights for therapy management
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research (2021) S. PS2 - 24Online Volltext: dx.doi.org/ -
Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells : results from the randomized phase III DETECT III trial
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PD3 - 12Online Volltext: dx.doi.org/ -
Natural transition targeted surgery
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS1 - 11Online Volltext: dx.doi.org/ -
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS2 - 02Online Volltext: dx.doi.org/ -
Real-world efficacy of ribociclib + aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer : Third interim analysis from the RIBANNA study
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS10 - 16Online Volltext: dx.doi.org/